Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 4953-4957

  Dufort, Fay J ^a   Bleiman, Blair F ^a   Gumina, Maria R ^a   Blair, Derek ^a   Wagner, Dean J ^c   Roberts, Mary F ^a   Abu Amer, Yousef ^b   Chiles, Thomas C ^a  

^a BOSTON COLLEGE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE P85 ALPHA; STAT6 PROTEIN; UNCLASSIFIED DRUG; GLUCOSE; STAT6 PROTEIN, MOUSE;

ALPHA CHAIN; ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLYCOLYSIS; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; ENERGY METABOLISM; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTE SUBSETS; CELL SURVIVAL; ENERGY METABOLISM; GLUCOSE; GLYCOLYSIS; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 38449099803     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.4953     Document Type: Article

References (24)

1. Van Parijs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280: 243-248.
2. Rathmell, J. C., M. G. Vander Heiden, M. H. Harris, K. A. Frauwirth, and C. B. Thompson. 2000. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6: 683-692.
3. Vander Heiden, M. G., D. R. Plas, J. C. Rathmell, C. J. Fox, M. H. Harris, and C. B. Thompson. 2001. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell Biol. 21: 5899-5912.
4. Rathmell, J. C., C. J. Fox, D. R. Plas, P. S. Hammerman, R. M. Cinalli, and C. B. Thompson. 2003. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23: 7315-7328.
5. Plas, D. R., and C. B. Thompson. 2002. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13: 75-78.
6. Garland, J. M., and A. Halestrap. 1997. Energy metabolism during apoptosis: Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J. Biol. Chem. 272: 4680-4688.
7. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17: 701-738.
8. Illera, V. A., C. E. Perandones, L. L. Stunz, D. A. Mower, Jr., and R. F. Ashman. 1993. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151: 2965-2973.
9. Wurster, A. L., V. L. Rodgers, M. F. White, T. L. Rothstein, and M. J. Grusby. 2002. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J. Biol. Chem. 277: 27169-27175.
10. Kelly-Welch, A., E. M. Hanson, and A. D. Keegan. 2005. Interleukin-4 (IL-4) pathway. Sci. STKE 2005: cm9.
11. Wurster, A. L., T. Tanaka, and M. J. Grusby. 2000. The biology of Stat4 and Stat6. Oncogene 19: 2577-2584.
12. Zamorano, J., H. Y. Wang, L. M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157: 4926-4934.
13. Morris, S. C., N. L. Dragula, and F. D. Finkelman. 2002. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production. J. Immunol. 169: 1696-1704.
14. Rathmell, J. C., E. A. Farkash, W. Gao, and C. B. Thompson. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167: 6869-6876.
15. Doughty, C. A., B. F. Bleiman, D. J. Wagner, F. J. Dufort, J. M. Mataraza, M. F. Roberts, and T. C. Chiles. 2006. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107: 4458-4465.
16. Withers, D. J., J. S. Gutierrez, H. Towery, D. J. Burks, J. M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G. I. Shulman, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904.
17. Hirayama, T., S. Dai, S. Abbas, Y. Yamanaka, and Y. Abu-Amer. 2005. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-κB activation. Arthritis Rheum. 52: 2719-2729.
18. Pelicano, H., D. S. Martin, R. H. Xu, and P. Huang. 2006. Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646.
19. Suzuki, H., Y. Terauchi, M. Fujiwara, S. Aizawa, Y. Yazaki, T. Kadowaki, and S. Koyasu. 1999. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283: 390-392.
20. Canfield, S., Y. Lee, A. Schroder, and P. Rothman. 2005. Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J. Immunol. 174: 2494-2498.
21. Schwarze, S. R., K. A. Hruska, and S. F. Dowdy. 2000. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10: 290-295.
22. Buttgereit, F., G. R. Burmester, and M. D. Brand. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21: 192-199.
23. Zhu, X., R. Hart, M. S. Chang, J. W. Kim, S. Y. Lee, Y. A. Cao, D. Mock, E. Ke, B. Saunders, A. Alexander, et al. 2004. Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands. J. Immunol. 173: 7141-7149.
24. Schroder, A. J., P. Pavlidis, A. Arimura, D. Capece, and P. B. Rothman. 2002. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J. Immunol. 168: 996-1000.